Home Cart Sign in  
Chemical Structure| 3391-86-4 Chemical Structure| 3391-86-4
Chemical Structure| 3391-86-4

*Storage: Inert atmosphere,Room Temperature.

Oct-1-en-3-ol

CAS No.: 3391-86-4

Synonyms: 1-Octen-3-ol;NSC 87563;Octenol

4.5 *For Research Use Only !

Cat. No.: A114632 Purity: 98%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
5g łÇʶÊÊ In Stock In Stock Login
10g łÇ˶ÊÊ In Stock In Stock Login
25g łÇî¶ÊÊ Inquiry In Stock Login
100g łÿ§¶ÊÊ In Stock In Stock Login
500g łÇò˶ÊÊ In Stock In Stock Login
1kg ł§ÊͶÊÊ Inquiry In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 5g

    łÇʶÊÊ

  • 10g

    łÇ˶ÊÊ

  • 25g

    łÇî¶ÊÊ

  • 100g

    łÿ§¶ÊÊ

  • 500g

    łÇò˶ÊÊ

  • 1kg

    ł§ÊͶÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 3391-86-4 ]

CAS No. :3391-86-4
Formula : C8H16O
Linear Structure Formula :CH2CHCH(C5H11)OH
M.W : 128.21
SMILES Code : C=CC(O)CCCCC
Synonyms :
1-Octen-3-ol;NSC 87563;Octenol
MDL No. :MFCD00004589
InChI Key :VSMOENVRRABVKN-UHFFFAOYSA-N
Pubchem ID :18827

Safety of [ 3391-86-4 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 3391-86-4 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 0
Fraction Csp3 0.75
Num. rotatable bonds 5
Num. H-bond acceptors 1.0
Num. H-bond donors 1.0
Molar Refractivity 41.26
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

20.23 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.33
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.55
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.11
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

2.07
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.96
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.21

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.91
Solubility 1.57 mg/ml ; 0.0123 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.62
Solubility 0.306 mg/ml ; 0.00239 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.77
Solubility 2.2 mg/ml ; 0.0171 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.27 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.15

Application In Synthesis [ 3391-86-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 3391-86-4 ]

[ 3391-86-4 ] Synthesis Path-Downstream   1~3

  • 1
  • [ 221044-05-9 ]
  • [ 3391-86-4 ]
  • 1-[1-(pyrimidin-2-yl)-1H-indol-2-yl]octan-3-one [ No CAS ]
YieldReaction ConditionsOperation in experiment
89% With silver hexafluoroantimonate; dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; In water; at 80℃; for 12h;Schlenk technique; Green chemistry; General procedure: Heterocycles 1 (0.2mmol, 1.0 equiv), allylic alcohols 2 (0.4 mmol, 2.0 equiv), [Cp*RhCl2]2 (2.5mol %), AgSbF6 (0.02mmol, 10mol %) and H2O (2mL) were charged into a Schlenk tube under air. The reaction mixture was stirred for 12hat 80C. After the reaction was complete, the mixture was extracted with CH2Cl2 three times. The combined organic layer was dried with anhydrous Na2SO4 and evaporated in vacuum. The crude product was purified by flash chromatography on silica gel using hexane/ethyl acetate as the eluent to give the pure product 3.
89% With silver hexafluoroantimonate; at 20℃; for 24h; To the polyethylene glycol-400 catalytic system obtained in Example 10 was added 1 mmol of N-pyrimidine indole and 2 mmol of 1-octen-3-ol,Stir at room temperature for 24 hours, monitor the progress of the reaction by TLC,After the reaction is complete, extract with ether three times,The obtained polyethylene glycol-400 catalytic system is reused,Put into the next experiment, combine the ether solution and concentrate, and separate it by column chromatography to obtain 287mg of light yellow oily liquid.The yield is 89%, the structural formula of the resulting product is as follows,The obtained polyethylene glycol-400 catalytic system was reused and put into the next experiment:
  • 2
  • [ 3391-86-4 ]
  • [ 551-11-1 ]
  • 3
  • [ 3391-86-4 ]
  • [ 551-11-1 ]
 

Related Products

Historical Records

Categories

Related Functional Groups of
[ 3391-86-4 ]

Alkenyls

Chemical Structure| 4277-34-3

A387207 [4277-34-3]

Cyclooct-4-enol

Similarity: 0.78

Chemical Structure| 821-41-0

A778791 [821-41-0]

5-Hexen-1-ol

Similarity: 0.75

Chemical Structure| 112-43-6

A849391 [112-43-6]

10-Undecen-1-ol

Similarity: 0.75

Chemical Structure| 515-03-7

A573023 [515-03-7]

(1R,2R,4aS,8aS)-1-((R)-3-Hydroxy-3-methylpent-4-en-1-yl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol

Similarity: 0.70

Chemical Structure| 821-09-0

A166788 [821-09-0]

Pent-4-en-1-ol

Similarity: 0.69

Aliphatic Chain Hydrocarbons

Chemical Structure| 821-41-0

A778791 [821-41-0]

5-Hexen-1-ol

Similarity: 0.75

Chemical Structure| 112-43-6

A849391 [112-43-6]

10-Undecen-1-ol

Similarity: 0.75

Chemical Structure| 123-96-6

A301403 [123-96-6]

Octan-2-ol

Similarity: 0.69

Chemical Structure| 5978-70-1

A466919 [5978-70-1]

(R)-2-Octanol

Similarity: 0.69

Chemical Structure| 543-49-7

A674099 [543-49-7]

Heptan-2-ol

Similarity: 0.69

Alcohols

Chemical Structure| 4277-34-3

A387207 [4277-34-3]

Cyclooct-4-enol

Similarity: 0.78

Chemical Structure| 821-41-0

A778791 [821-41-0]

5-Hexen-1-ol

Similarity: 0.75

Chemical Structure| 112-43-6

A849391 [112-43-6]

10-Undecen-1-ol

Similarity: 0.75

Chemical Structure| 515-03-7

A573023 [515-03-7]

(1R,2R,4aS,8aS)-1-((R)-3-Hydroxy-3-methylpent-4-en-1-yl)-2,5,5,8a-tetramethyldecahydronaphthalen-2-ol

Similarity: 0.70

Chemical Structure| 123-96-6

A301403 [123-96-6]

Octan-2-ol

Similarity: 0.69